Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer.

Thrombosis research - 1 Jan 2003

Eroğlu Aydan, Cam Ragip, Yildiz Züleyha, Akar Nejat

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Comorbidity
Share to Factor V
Share to Prevalence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prothrombin

Share to Tamoxifen

Share to Thromboembolism

Share to Turkey

Source

Identifiers

PMID: 14693181
DOI: 10.1016/j.thromres.2003.09.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer.PMID 14693181Read ↗

Prothrombotic genotypes and risk of venous thromboembolism in cancer.Semantic proximity Read ↗

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Semantic proximity Read ↗

Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.Semantic proximity Read ↗

Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.Semantic proximity Read ↗

Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.Semantic proximity Read ↗

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.Semantic proximity Read ↗

Malignancies, prothrombotic mutations, and the risk of venous thrombosis.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

The Association of Prothrombin Gene G20210A Mutation with Recurrent Venous Thromboembolism: Evidence from a Meta-Analysis.Semantic proximity Read ↗

The prothrombin 20210 G to A variation and thrombosis.Semantic proximity Read ↗

Investigating the Matrix of Factor V Leiden (G1691A), Factor II Prothrombin (G2021A), MTHFR C677T and A1298G Polymorphisms in Greek Population: A Preliminary Study.Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.